Goldman Sachs’s Biomea Fusion BMEA Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEA
ACM
FISPB
Goldman Sachs's BMEA Position: Q2 2026 in Review
Goldman Sachs increased its Biomea Fusion (BMEA) stake by 24% in Q2 2026, buying an estimated $26.9K and bringing the position to 93,757 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #6293.
Goldman Sachs first reported a position in BMEA in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.2M in Q1 2024. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.
- Goldman Sachs held 93,757 shares of Biomea Fusion worth $138K as of Q2 2026.
- Goldman Sachs bought 18,018 Biomea Fusion shares in Q2 2026, an estimated $26.9K.
- Biomea Fusion made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6293 holding.
- Goldman Sachs first reported a position in Biomea Fusion in Q4 2021 and has held it in 19 quarters since.
- Goldman Sachs's Biomea Fusion position peaked at $5.2M in Q1 2024.
- 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.